Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 Expression of coagulation protease receptors in renal cells

Published byRobyn Johnston Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 4 Expression of coagulation protease receptors in renal cells"— Presentation transcript:

1 Figure 4 Expression of coagulation protease receptors in renal cells
Figure 4 | Expression of coagulation protease receptors in renal cells. Protease activated receptor (PAR) 2 is expressed on all types of human renal cells but is not expressed on murine podocytes, whereas PAR3 expression is predominantly restricted to podocytes. Endothelial protein C receptor (EPCR), which promotes protein C activation and activated protein C signalling, is expressed by glomerular endothelial and tubular epithelial cells. Tissue factor (TF) is expressed by podocytes and mesangial cells in humans, whether it is expressed on these cells in other species remains unproven. In various disease models (for example sepsis and diabetic nephropathy) TF expression is induced, but expression of thrombomodulin and EPCR is impaired. Kerlin, B. A. & Isermann, B. et al. (2015) The emerging role of coagulation proteases in kidney disease Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 4 Expression of coagulation protease receptors in renal cells"

Similar presentations

Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).

Figure 1 Disruption of phosphate homeostasis in chronic kidney disease (CKD) Figure 1 | Disruption of phosphate homeostasis in chronic kidney disease (CKD).
Figure 2 Cell-mediated disease mechanisms of lupus nephritis

Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Figure 3 LncRNAs in kidney disease

Figure 3 LncRNAs in kidney disease
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Figure 3 Angiotensin signalling in adiporenal crosstalk

Figure 3 Angiotensin signalling in adiporenal crosstalk
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Physiological changes in the renal system in pregnancy

Figure 2 Physiological changes in the renal system in pregnancy
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Role of the kidney in glucose homeostasis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.

Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.
Figure 7 The efficacy of phosphate-binder therapy

Figure 7 The efficacy of phosphate-binder therapy
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)

Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)
Figure 1 Targets for monoclonal antibodies in B-cell lineages

Figure 1 Targets for monoclonal antibodies in B-cell lineages
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 2 The network of chronic diseases and their mutual influences

Figure 2 The network of chronic diseases and their mutual influences
Figure 2 Three distinct mechanisms of activation of

Figure 2 Three distinct mechanisms of activation of

Similar presentations

Ads by Google